Results 201 to 205 of about 28,618 (205)

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes

Cancer Immunology, Immunotherapy, 2013
Alessia Parodi, Florinda Battaglia, Francesca Kalli   +2 more
exaly  

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse

Journal of Neuroimmunology, 2011
Evelyn Peelen, Jan Damoiseaux, Joost Smolders   +2 more
exaly  

Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response

Biomolecules
M Angels Ortiz, Cesar Diaz-Torne, Delia Reina   +2 more
exaly  

CD39 transforming cancer therapy by modulating tumor microenvironment

Cancer Letters
Qingqing Wang, Wenxue Ma
exaly  

Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease

Cellular and Molecular Immunology
Eva Csizmadia, Maria Serena Longhi, Csizmadia Eva   +2 more
exaly